
11 - 50 employees
Founded 1997
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
Biotechnology • Healthcare • Pharmaceuticals
Altimmune is a late-stage clinical biopharmaceutical company focused on developing therapies for serious liver diseases. The company’s pipeline targets conditions with high unmet need including metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). Its lead candidate, pemvidutide, is an investigational therapy designed to address liver disease via glucagon receptor activity and metabolic effects through GLP-1 activity. Altimmune advances treatments by addressing fundamental mechanisms driving liver disease progression.
Selected: 🆕 Date Added.
🔥 3 hours ago
Pharmacovigilance operations director overseeing drug safety systems, vendors, inspections, and compliance. Supporting Altimmune’s clinical-stage liver-disease therapies and cross-functional regulatory execution.